Skip to main content

Table 3 Association between microRNA-144-3p expression and clinicopathological parameters in lung adenocarcinoma, based on The Cancer Genome Atlas data

From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

Clinicopathological   n mean ± SD p value
Tissue Adjacent non-cancerous tissue 43 5.2775 ± 1.64708 < 0.001*
LUAD 445 2.8959 ± 1.35967
Age (years) < 60 120 3.0042 ± 1.40207 0.168
≥60 306 2.7979 ± 1.33460
Gender Female 239 2.9011 ± 1.33672 0.931
Male 206 2.8898 ± 1.38905
Tumor location Central lung 54 2.5665 ± 1.1857 0.382
Peripheral lung 113 2.747 ± 1.3564
Stage Stage I-II 349 2.8191 ± 1.33042 0.031*
Stage III-IV 91 3.1868 ± 1.45395
T T1-T2 385 2.9199 ± 1.35515 0.133
T3-T4 57 2.6359 ± 1.3106
N No 291 2.8546 ± 1.35977 0.553
Yes 145 2.9367 ± 1.35784
M No 283 2.8058 ± 1.31875 0.126
Yes 19 3.3343 ± 1.4003
  1. SD Standard deviation, LUAD Lung adenocarcinoma
  2. *p < 0.05 was considered statistically significant